- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00007761
Does Bipolar Disease Program (BDP) Intervention Improve Long Term Manic and Depressive Symptoms.
CSP #430 - Reducing The Efficacy-Effectiveness Gap In Bipolar Disorder
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Primary Hypothesis: The primary hypotheses are that Bipolar Disease Program (BDP) intervention will significantly improve (1) manic and (2) depressive symptom scores, as well as Total Treatment Costs as compared to usual care of bipolar patients.
Secondary Hypothesis: Secondary hypotheses include significant improvement in BDP patients as compared to usual bipolar treatment care with respect to functional outcome, quality of life, intensity of somatotherapy, patient satisfaction, and provider attitudes.
Intervention: Usual (psychiatric) Care vs Bipolar Disorder Program
Primary Outcomes: The primary outcomes are: (1) Manic Symptom Score; (2) Depressive Symptom Score; and (3) Total Treatment Costs.
Study Abstract: Based on highly promising preliminary data, it is proposed to conduct a multi-site randomized controlled trial of a high-intensity ambulatory treatment program for bipolar disorder against standard office-based, physician-centered care. The major characteristics of this program are that it emphasizes (1) aggressive guideline-driven pharmacotherapy, (2) continuity of care with identified primary mental health nurse clinicians supported by psychiatrist back-up, and (3) patient education to improve treatment alliance and illness management skills.
Patients with bipolar disorder will be randomly assigned to either standard care or the high intensity ambulatory program for three years. Outcome variables will cover three distinct domains: disease-specific outcome (number, length, and severity of manic and depressive episodes), functional outcome (social and occupational role function and subjective quality of life), and total treatment costs (direct treatment costs and indirect costs of illness). Preliminary data indicate that these domains are related but not redundant. Each of these is relevant to patient well-being and to VHA management.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
Arizona
-
Tucson, Arizona, Forenede Stater, 85723
- Southern Arizona VA Health Care System, Tucson
-
-
California
-
Palo Alto, California, Forenede Stater, 94304-1290
- VA Palo Alto Health Care System
-
San Diego, California, Forenede Stater, 92161
- VA San Diego Healthcare System, San Diego
-
West Los Angeles, California, Forenede Stater, 90073
- VA Greater Los Angeles Healthcare System, West LA
-
-
Colorado
-
Denver, Colorado, Forenede Stater, 80220
- VA Eastern Colorado Health Care System, Denver
-
-
Connecticut
-
West Haven, Connecticut, Forenede Stater, 06516
- VA Connecticut Health Care System (West Haven)
-
-
Georgia
-
Augusta, Georgia, Forenede Stater, 30904
- VA Medical Center, Augusta
-
-
Illinois
-
Hines, Illinois, Forenede Stater, 60141-5000
- Edward Hines, Jr. VA Hospital
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46202-2884
- Richard Roudebush VA Medical Center, Indianapolis
-
-
Massachusetts
-
Brockton, Massachusetts, Forenede Stater, 02301
- VA Boston Healthcare System, Brockton Campus
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44106
- VA Medical Center, Cleveland
-
-
Tennessee
-
Mountain Home, Tennessee, Forenede Stater, 37684
- James H. Quillen VA Medical Center
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75216
- VA North Texas Health Care System, Dallas
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Patients with bipolar disorder. Index episode of manic, major depression or both requiring hospitalization on acute unit. At lease two hospitalizations, three or more months apart within the past 5 years.
Exclusion Criteria:
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: 1
Bipolar Disorder Program
|
|
Aktiv komparator: 2
Usual (psychiatric) Care
|
Samarbejdspartnere og efterforskere
Efterforskere
- Studiestol: Mark S Bauer, MD BA, VA Boston Healthcare System, Brockton Campus
Publikationer og nyttige links
Generelle publikationer
- Pirraglia PA, Biswas K, Kilbourne AM, Fenn H, Bauer MS. A prospective study of the impact of comorbid medical disease on bipolar disorder outcomes. J Affect Disord. 2009 Jun;115(3):355-9. doi: 10.1016/j.jad.2008.09.020. Epub 2008 Oct 18.
- Brown GR, McBride L, Bauer MS, Williford WO; Cooperative Studies Program 430 Study Team. Impact of childhood abuse on the course of bipolar disorder: a replication study in U.S. veterans. J Affect Disord. 2005 Dec;89(1-3):57-67. doi: 10.1016/j.jad.2005.06.012. Epub 2005 Oct 4.
- Bauer MS, Williford WO, McBride L, McBride K, Shea NM. Perceived barriers to health care access in a treated population. Int J Psychiatry Med. 2005;35(1):13-26. doi: 10.2190/U1D5-8B1D-UW69-U1Y4.
- Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R; VA Cooperative Study #430 Team. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord. 2005 Apr;85(3):301-15. doi: 10.1016/j.jad.2004.11.009.
- Bauer MS, Mitchner L. What is a "mood stabilizer"? An evidence-based response. Am J Psychiatry. 2004 Jan;161(1):3-18. doi: 10.1176/appi.ajp.161.1.3.
- Glick HA, McBride L, Bauer MS. A manic-depressive symptom self-report in optical scanable format. Bipolar Disord. 2003 Oct;5(5):366-9. doi: 10.1034/j.1399-5618.2003.00043.x.
- Bauer MS. An evidence-based review of psychosocial treatments for bipolar disorder. Psychopharmacol Bull. 2001 Summer;35(3):109-34.
- Bauer MS. A review of quantitative studies of adherence to mental health clinical practice guidelines. Harv Rev Psychiatry. 2002 May-Jun;10(3):138-53. doi: 10.1080/10673220216217.
- Bauer MS. The collaborative practice model for bipolar disorder: design and implementation in a multi-site randomized controlled trial. Bipolar Disord. 2001 Oct;3(5):233-44. doi: 10.1034/j.1399-5618.2001.30502.x.
- Bauer MS, Kirk GF, Gavin C, Williford WO. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. J Affect Disord. 2001 Aug;65(3):231-41. doi: 10.1016/s0165-0327(00)00247-0.
- Vojta C, Kinosian B, Glick H, Altshuler L, Bauer MS. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry. 2001 May-Jun;42(3):190-5. doi: 10.1053/comp.2001.23143.
- Bauer MS, Vojta C, Kinosian B, Altshuler L, Glick H. The Internal State Scale: replication of its discriminating abilities in a multisite, public sector sample. Bipolar Disord. 2000 Dec;2(4):340-6. doi: 10.1034/j.1399-5618.2000.020409.x.
- Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr Serv. 2008 Jul;59(7):753-9. doi: 10.1176/ps.2008.59.7.753.
- Altshuler L, Tekell J, Biswas K, Kilbourne AM, Evans D, Tang D, Bauer MS. Executive function and employment status among veterans with bipolar disorder. Psychiatr Serv. 2007 Nov;58(11):1441-7. doi: 10.1176/ps.2007.58.11.1441.
- Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M; Cooperative Studies Program 430 Study Team. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006 Jul;57(7):937-45. doi: 10.1176/ps.2006.57.7.937.
- Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M; Cooperative Studies Program 430 Study Team. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv. 2006 Jul;57(7):927-36. doi: 10.1176/ps.2006.57.7.927.
- Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr Serv. 2006 Jan;57(1):56-62. doi: 10.1176/appi.ps.57.1.56.
- Fenn HH, Bauer MS, Altshuler L, Evans DR, Williford WO, Kilbourne AM, Beresford TP, Kirk G, Stedman M, Fiore L; VA Cooperative Study #430 Team. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord. 2005 May;86(1):47-60. doi: 10.1016/j.jad.2004.12.006. Erratum In: J Affect Disord. 2006 Feb;90(2-3):275. Alshuler, Lori [corrected to Altshuler, Lori].
- Kilbourne AM, Bauer MS, Pincus H, Williford WO, Kirk GF, Beresford T; Veterans Administration (VA) Cooperative Study #430 Team. Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder. Bipolar Disord. 2005 Feb;7(1):89-97. doi: 10.1111/j.1399-5618.2004.00161.x.
- Glick HA, Kinosian B, McBride L, Williford WO, Bauer MS; CSP #430 Study Team. Clinical nurse specialist care managers' time commitments in a disease-management program for bipolar disorder. Bipolar Disord. 2004 Dec;6(6):452-9. doi: 10.1111/j.1399-5618.2004.00159.x.
- Polsky D, Onesirosan P, Bauer MS, Glick HA. Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans. J Clin Psychiatry. 2002 Feb;63(2):156-64. doi: 10.4088/jcp.v63n0212.
- Bauer MS, Williford WO, Dawson EE, Akiskal HS, Altshuler L, Fye C, Gelenberg A, Glick H, Kinosian B, Sajatovic M. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. J Affect Disord. 2001 Dec;67(1-3):61-78. doi: 10.1016/s0165-0327(01)00440-2.
- Kilbourne AM, Biswas K, Pirraglia PA, Sajatovic M, Williford WO, Bauer MS. Is the collaborative chronic care model effective for patients with bipolar disorder and co-occurring conditions? J Affect Disord. 2009 Jan;112(1-3):256-61. doi: 10.1016/j.jad.2008.04.010. Epub 2008 May 27.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 430
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Maniodepressiv
-
ProgenaBiomeRekrutteringManiodepressiv | Bipolar I lidelse | Bipolar II lidelse | Bipolar type I lidelse | Bipolar lidelse Mild | Bipolar lidelse Moderat | Bipolar lidelse AlvorligForenede Stater
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SAfsluttetBipolar IForenede Stater, Frankrig, Rumænien, Polen, Canada, Ungarn, Japan, Korea, Republikken, Malaysia, Taiwan
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationAfsluttetManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar lidelse I | Bipolar affektiv lidelseForenede Stater
-
Region StockholmKarolinska InstitutetRekrutteringManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar II lidelse | Bipolar affektiv lidelse; Remission i | Bipolar affektiv lidelse, i øjeblikket deprimeret, moderatSverige
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionAfsluttetBipolar I lidelse | Bipolar II lidelse | Bipolar lidelse NOSForenede Stater
-
Joshua RosenblatRekrutteringManiodepressiv | Bipolar depression | Bipolar I lidelse | Bipolar II lidelseCanada
-
University of ChicagoAfsluttet
-
Solvay PharmaceuticalsWyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/SAfsluttet
-
University of Sao PauloAfsluttetBipolar I lidelseBrasilien
-
University of Sao PauloUkendt
Kliniske forsøg med Bipolar Disorder Program
-
Swinburne University of TechnologyNational Health and Medical Research Council, Australia; University of... og andre samarbejdspartnereAfsluttetBipolar lidelse, i øjeblikket i remissionAustralien
-
Chinese University of Hong KongThe University of Hong Kong; Queen Elizabeth Hospital, Hong Kong; North District... og andre samarbejdspartnereAfsluttet
-
Medtronic Surgical TechnologiesAfsluttetBetændelse | Blødning | Gigt | Slidgigt | Kirurgi | Handicap | InfektionDet Forenede Kongerige
-
Selcuk UniversitySuspenderet
-
Mansoura UniversityAfsluttetProstata hypertrofi | Holmium laser | Thulium laser | Bipolar diatermi | Prostata EnucleationEgypten
-
Assiut UniversityIkke rekrutterer endnu
-
Mental Health Services in the Capital Region, DenmarkMaria Faurholt-Jepsen, MD, DMSc; The Mental Health Services in the Capital...Rekruttering
-
Srinivas DukkipatiBiosense Webster, Inc.Afsluttet
-
Mahidol UniversityUkendt
-
AtriCure, Inc.AfsluttetAtrieflimrenForenede Stater